Factors Predictive of Relapse of Acute Leukemia in Children after Allogeneic Hematopoietic Cell Transplantation

Nirali N. Shah, Michael J. Borowitz, Seth M. Steinberg, Nancy C. Robey, Christopher J. Gamper, Heather J. Symons, David M. Loeb, Alan S. Wayne, Allen R. Chen

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

The presence of minimal residual disease (MRD) before transplantation is the most important prognostic risk factor predictive of post-transplantation relapse in hematologic malignancies. However, MRD alone does not adequately predict relapse in all patients. To improve upon the ability to identify patients likely to relapse, we evaluated risk factors, in addition to MRD, that may be associated with development of post-transplantation relapse. In this single institution, retrospective cohort study of children with acute leukemia or myelodysplastic syndrome who had undergone a first allogeneic transplantation and had pretransplantation MRD evaluation, 40 of 93 patients (43%) experienced relapse. Univariate analysis demonstrated that African American race, high initial white blood cell count, central nervous system (CNS) disease at diagnosis, short first complete remission, nonmyeloablative (NMA) conditioning, lack of remission, and MRD before transplantation were associated with worse relapse-free survival (RFS). In a Cox multivariable analysis, CNS disease (P = .009), lack of remission (P = .01), and NMA conditioning (P = .04) were independently associated with inferior RFS. Among those in a morphologic complete remission who underwent a myeloablative transplantation, having both CNS disease at diagnosis (specifically in acute lymphoblastic leukemia) and MRD positivity was an independent risk factor predictive of relapse, which has not been previously reported. Results from our study support the existence of risk factors complimentary to pretransplantation MRD. Validation in a larger independent homogenous cohort is needed to develop a prognostic tool for clinical use to predict post-transplantation relapse.

Original languageEnglish (US)
Pages (from-to)1033-1039
Number of pages7
JournalBiology of Blood and Marrow Transplantation
Volume20
Issue number7
DOIs
StatePublished - Jan 1 2014
Externally publishedYes

Fingerprint

Cell Transplantation
Residual Neoplasm
Leukemia
Recurrence
Transplantation
Central Nervous System Diseases
Survival
Myelodysplastic Syndromes
Homologous Transplantation
Hematologic Neoplasms
Leukocyte Count
Precursor Cell Lymphoblastic Leukemia-Lymphoma
African Americans
Cohort Studies
Retrospective Studies

Keywords

  • Leukemia
  • Minimal residual disease
  • Post-transplantation relapse
  • Risk factors

ASJC Scopus subject areas

  • Hematology
  • Transplantation

Cite this

Shah, N. N., Borowitz, M. J., Steinberg, S. M., Robey, N. C., Gamper, C. J., Symons, H. J., ... Chen, A. R. (2014). Factors Predictive of Relapse of Acute Leukemia in Children after Allogeneic Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation, 20(7), 1033-1039. https://doi.org/10.1016/j.bbmt.2014.03.028

Factors Predictive of Relapse of Acute Leukemia in Children after Allogeneic Hematopoietic Cell Transplantation. / Shah, Nirali N.; Borowitz, Michael J.; Steinberg, Seth M.; Robey, Nancy C.; Gamper, Christopher J.; Symons, Heather J.; Loeb, David M.; Wayne, Alan S.; Chen, Allen R.

In: Biology of Blood and Marrow Transplantation, Vol. 20, No. 7, 01.01.2014, p. 1033-1039.

Research output: Contribution to journalArticle

Shah, NN, Borowitz, MJ, Steinberg, SM, Robey, NC, Gamper, CJ, Symons, HJ, Loeb, DM, Wayne, AS & Chen, AR 2014, 'Factors Predictive of Relapse of Acute Leukemia in Children after Allogeneic Hematopoietic Cell Transplantation', Biology of Blood and Marrow Transplantation, vol. 20, no. 7, pp. 1033-1039. https://doi.org/10.1016/j.bbmt.2014.03.028
Shah, Nirali N. ; Borowitz, Michael J. ; Steinberg, Seth M. ; Robey, Nancy C. ; Gamper, Christopher J. ; Symons, Heather J. ; Loeb, David M. ; Wayne, Alan S. ; Chen, Allen R. / Factors Predictive of Relapse of Acute Leukemia in Children after Allogeneic Hematopoietic Cell Transplantation. In: Biology of Blood and Marrow Transplantation. 2014 ; Vol. 20, No. 7. pp. 1033-1039.
@article{db40734ebb264f2c94ac3b98fa012e24,
title = "Factors Predictive of Relapse of Acute Leukemia in Children after Allogeneic Hematopoietic Cell Transplantation",
abstract = "The presence of minimal residual disease (MRD) before transplantation is the most important prognostic risk factor predictive of post-transplantation relapse in hematologic malignancies. However, MRD alone does not adequately predict relapse in all patients. To improve upon the ability to identify patients likely to relapse, we evaluated risk factors, in addition to MRD, that may be associated with development of post-transplantation relapse. In this single institution, retrospective cohort study of children with acute leukemia or myelodysplastic syndrome who had undergone a first allogeneic transplantation and had pretransplantation MRD evaluation, 40 of 93 patients (43{\%}) experienced relapse. Univariate analysis demonstrated that African American race, high initial white blood cell count, central nervous system (CNS) disease at diagnosis, short first complete remission, nonmyeloablative (NMA) conditioning, lack of remission, and MRD before transplantation were associated with worse relapse-free survival (RFS). In a Cox multivariable analysis, CNS disease (P = .009), lack of remission (P = .01), and NMA conditioning (P = .04) were independently associated with inferior RFS. Among those in a morphologic complete remission who underwent a myeloablative transplantation, having both CNS disease at diagnosis (specifically in acute lymphoblastic leukemia) and MRD positivity was an independent risk factor predictive of relapse, which has not been previously reported. Results from our study support the existence of risk factors complimentary to pretransplantation MRD. Validation in a larger independent homogenous cohort is needed to develop a prognostic tool for clinical use to predict post-transplantation relapse.",
keywords = "Leukemia, Minimal residual disease, Post-transplantation relapse, Risk factors",
author = "Shah, {Nirali N.} and Borowitz, {Michael J.} and Steinberg, {Seth M.} and Robey, {Nancy C.} and Gamper, {Christopher J.} and Symons, {Heather J.} and Loeb, {David M.} and Wayne, {Alan S.} and Chen, {Allen R.}",
year = "2014",
month = "1",
day = "1",
doi = "10.1016/j.bbmt.2014.03.028",
language = "English (US)",
volume = "20",
pages = "1033--1039",
journal = "Biology of Blood and Marrow Transplantation",
issn = "1083-8791",
publisher = "Elsevier Inc.",
number = "7",

}

TY - JOUR

T1 - Factors Predictive of Relapse of Acute Leukemia in Children after Allogeneic Hematopoietic Cell Transplantation

AU - Shah, Nirali N.

AU - Borowitz, Michael J.

AU - Steinberg, Seth M.

AU - Robey, Nancy C.

AU - Gamper, Christopher J.

AU - Symons, Heather J.

AU - Loeb, David M.

AU - Wayne, Alan S.

AU - Chen, Allen R.

PY - 2014/1/1

Y1 - 2014/1/1

N2 - The presence of minimal residual disease (MRD) before transplantation is the most important prognostic risk factor predictive of post-transplantation relapse in hematologic malignancies. However, MRD alone does not adequately predict relapse in all patients. To improve upon the ability to identify patients likely to relapse, we evaluated risk factors, in addition to MRD, that may be associated with development of post-transplantation relapse. In this single institution, retrospective cohort study of children with acute leukemia or myelodysplastic syndrome who had undergone a first allogeneic transplantation and had pretransplantation MRD evaluation, 40 of 93 patients (43%) experienced relapse. Univariate analysis demonstrated that African American race, high initial white blood cell count, central nervous system (CNS) disease at diagnosis, short first complete remission, nonmyeloablative (NMA) conditioning, lack of remission, and MRD before transplantation were associated with worse relapse-free survival (RFS). In a Cox multivariable analysis, CNS disease (P = .009), lack of remission (P = .01), and NMA conditioning (P = .04) were independently associated with inferior RFS. Among those in a morphologic complete remission who underwent a myeloablative transplantation, having both CNS disease at diagnosis (specifically in acute lymphoblastic leukemia) and MRD positivity was an independent risk factor predictive of relapse, which has not been previously reported. Results from our study support the existence of risk factors complimentary to pretransplantation MRD. Validation in a larger independent homogenous cohort is needed to develop a prognostic tool for clinical use to predict post-transplantation relapse.

AB - The presence of minimal residual disease (MRD) before transplantation is the most important prognostic risk factor predictive of post-transplantation relapse in hematologic malignancies. However, MRD alone does not adequately predict relapse in all patients. To improve upon the ability to identify patients likely to relapse, we evaluated risk factors, in addition to MRD, that may be associated with development of post-transplantation relapse. In this single institution, retrospective cohort study of children with acute leukemia or myelodysplastic syndrome who had undergone a first allogeneic transplantation and had pretransplantation MRD evaluation, 40 of 93 patients (43%) experienced relapse. Univariate analysis demonstrated that African American race, high initial white blood cell count, central nervous system (CNS) disease at diagnosis, short first complete remission, nonmyeloablative (NMA) conditioning, lack of remission, and MRD before transplantation were associated with worse relapse-free survival (RFS). In a Cox multivariable analysis, CNS disease (P = .009), lack of remission (P = .01), and NMA conditioning (P = .04) were independently associated with inferior RFS. Among those in a morphologic complete remission who underwent a myeloablative transplantation, having both CNS disease at diagnosis (specifically in acute lymphoblastic leukemia) and MRD positivity was an independent risk factor predictive of relapse, which has not been previously reported. Results from our study support the existence of risk factors complimentary to pretransplantation MRD. Validation in a larger independent homogenous cohort is needed to develop a prognostic tool for clinical use to predict post-transplantation relapse.

KW - Leukemia

KW - Minimal residual disease

KW - Post-transplantation relapse

KW - Risk factors

UR - http://www.scopus.com/inward/record.url?scp=84901986778&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84901986778&partnerID=8YFLogxK

U2 - 10.1016/j.bbmt.2014.03.028

DO - 10.1016/j.bbmt.2014.03.028

M3 - Article

C2 - 24691222

AN - SCOPUS:84901986778

VL - 20

SP - 1033

EP - 1039

JO - Biology of Blood and Marrow Transplantation

JF - Biology of Blood and Marrow Transplantation

SN - 1083-8791

IS - 7

ER -